Charles Greg Guyer - Mar 15, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Technical Officer
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 15, 2024
Transactions value $
-$1,712,961
Form type
4
Date filed
3/19/2024, 08:50 PM
Previous filing
Feb 29, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +10.6K +11.96% $0.00 98.8K Mar 15, 2024 Direct F1
transaction BMRN Common Stock Tax liability -$1.71M -20.4K -20.68% $83.87 78.3K Mar 15, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Award $0 +23.6K $0.00 23.6K Mar 15, 2024 Common Stock 23.6K $83.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted March 15, 2024. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.